Commodore Capital’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $69.1M | Sell |
|
|||||
|
2025
Q2 | $68.2M | Buy |
|
|||||
|
2025
Q1 | $48.5M | Buy |
|
|||||
|
2024
Q4 | $46M | Sell |
|
|||||
|
2024
Q3 | $58M | Buy |
|
|||||
|
2024
Q2 | $32.9M | Buy |
|
|||||
|
2024
Q1 | $33.9M | Buy |
|
|||||
|
2023
Q4 | $41.9M | Sell |
|
|||||
|
2023
Q3 | $33.7M | Hold |
|
|||||
|
2023
Q2 | $52.3M | Buy |
|
|||||
|
2023
Q1 | $55.7M | Buy |
|
|||||
|
2022
Q4 | $59M | Sell |
|
|||||
|
2022
Q3 | $55.3M | Buy |
|
|||||
|
2022
Q2 | $19M | Buy |
|
|||||
|
2022
Q1 | $17.6M | Buy |
|
|||||
|
2021
Q4 | $16.8M | Buy |
|
|||||
|
2021
Q3 | $11M | Buy |
|
|||||
|
2021
Q2 | $3.41M | Buy |
|
|||||
|
2021
Q1 | $3.1M | Buy |
|